Dupixent Approved to Treat Eczema
TUESDAY, March 28, 2017 -- Dupixent (dupilumab) has been approved by the U.S. Food and Drug Administration to treat moderate-to-severe eczema that isn ' t well controlled by topical medication.
Eczema, medically called atopic dermatitis, is a chronic...
Source: Drugs.com - Daily MedNews - Category: Journals (General) Source Type: news
More News: Dermatitis | Dermatology | Eczema | Food and Drug Administration (FDA) | General Medicine